Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LCK inhibitors(Tyrosine-protein kinase LCK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization DELiver Therapeutics, Inc.Startup |
Active Organization DELiver Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | DELiver Therapeutics, Inc.Startup | 22 Sep 2024 |
Colorectal Cancer | Preclinical | US | DELiver Therapeutics, Inc.Startup | 22 Sep 2024 |
Lung Cancer | Preclinical | US | DELiver Therapeutics, Inc.Startup | 22 Sep 2024 |
Ovarian Cancer | Preclinical | US | DELiver Therapeutics, Inc.Startup | 22 Sep 2024 |